Peter Connick
www.annerowlingclinic.com
0000-0002-3892-8037
University of Edinburgh
2 papers found
Refreshing results…
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT
Missing publications? Search for publications with a matching author name.